secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptose Biosciences Inc. (APTOF)
CIK:        0000882361
Form:       8-K
Filed at:   2025-04-01T23:59:59+00:00
Accession:  0001171843-25-001910
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptose (APTO) to delist from Nasdaq April 2 for equity non-compliance
---------------------------------------------------------------------

- Nasdaq determined to delist Aptose common shares effective April 2, 2025 for failure to meet equity requirement (Listing Rule 5550(b)(1)).
- Company confirmed on March 31, 2025 it could not regain compliance by the Panel's final extended deadline.
- Trading suspended at open on April 2; shares continue trading on TSX under symbol APS.
- Board reviewing options, including possible appeal; company seeks to relist on a U.S. exchange at appropriate time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882361/000117184325001910/0001171843-25-001910-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882361/000117184325001910/f8k_040125.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-001910

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer